Spectrum Solutions Saliva Collection Device, Access Bio, Genalyte Coronavirus Tests Get FDA EUAs
Oct 12, 2020 | staff reporterNEW YORK — The US Food and Drug Administration on Thursday granted separate Emergency Use Authorizations (EUAs) for Spectrum Solutions' saliva collection device for SARS-CoV-2 tests, as well as SARS-CoV-2 tests developed by Access Bio and Genalyte.Spectrum's SDNA-1000 Saliva Collection Device consists of a plastic tube designed for the collection of human saliva samples suspected of containing SARS-CoV-2 RNA, a funnel, a cap with a stem flare, and a fluid chamber containing a patented stabilizing solution, according to the FDA.It has been evaluated with various RNA extraction chemistries including PerkinElmer's Chemagic Viral DNA/RNA 300 Kit, Thermo Fisher Scientific's MagMax Viral/Pathogen II Nucleic Acid Extraction Kit, Qiagen's QIAsymphony DSP Virus/Pathogen Midi Kit, and Roche's Magna Pure LC Total Nucleic Acid Isolation Kit.The device may be manufactured only by Draper, Utah-based Spectrum. It is used with DxTerity Diagnostics' DxTerity SARS-CoV-2 RT-PCR CE Test and RUCDR Infinite Biologics' saliva-based SARS-CoV-2 test.Access Bio's CareStart COVID-19 Antigen test is a visually read lateral flow immunochromatographic assay designed to detect the nucleocapsid protein antigen from SARS CoV-2 in nasopharyngeal swab specimens. Results are provided in 10 minutes, according to Access Bio.The test may be used by labs that are CLIA-certified to perform high-, moderate-, or waived-complexity tests, and is authorized for point-of-care use, the FDA said.In July, Somerset, New Jersey-based Access Bio received EUAs from the FDA for its CareStart COVID-19 IgM/IgG SARS-CoV-2 test and its CareStart COVID-19 MDx RT-PCR test. Genalyte's Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2 is designed to detect total antibodies, including immunoglobulin G and M, against the virus in whole blood, plasma, and serum. It runs on the San Diego-based company's Maverick Detection System, which uses photonic ring resonance technology for rapid blood testing.The test may be used by labs CLIA-certified to perform moderate- or high-complexity tests, according to the FDA.
- Forums
- ASX - By Stock
- AT1
- Media Update
Media Update, page-9
- There are more pages in this discussion • 1,837 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $19.81M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.9¢ | $4.745K | 159.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 123968 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 53324 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 123968 | 0.030 |
10 | 1003962 | 0.028 |
4 | 465185 | 0.027 |
3 | 712307 | 0.026 |
6 | 382402 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 53324 | 2 |
0.032 | 160150 | 3 |
0.033 | 755000 | 7 |
0.035 | 259761 | 6 |
0.036 | 330000 | 3 |
Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
3.1¢ |
  |
Change
0.001 ( 3.33 %) |
|||
Open | High | Low | Volume | ||
3.0¢ | 3.1¢ | 2.9¢ | 32795 | ||
Last updated 15.59pm 03/05/2024 ? |
Featured News
AT1 (ASX) Chart |